This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More
 

Real Money Previews

China Economic Data; Scoop on Monitise: Best of Kass

In these highlights from his trading diary in the past week, Doug Kass writes about China's GDP, volatile swings in the market and Monitise.

Excellent Earnings, Tough Audience; Surprises Among the Leaders: Jim Cramer's Best Blogs

Catch up on Jim Cramer's thinking over the past week about how this earnings season is excellent despite the haters, and why utilities and oil stocks are top performers now.

Jim Cramer: We're in the Grips of a Struggle

Companies that are inventing incredibly important drugs go down almost every day.

Mad Money Recap

'Mad Money' Lightning Round: Why Is Whole Foods' Stock Down?

Cramer says it's time to buy BlackRock and move on from Hologic.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to find the stocks he and Stephanie Link think could be HUGE winners. Click here to see them for FREE.

Stock Ideas

Biofuels Survive a Really Bad Day

Reports that current biofuel technology contributes to climate change aren't dissuading the industry's boosters.

Why Intel Does Not Need Smartphones or Tablets

Intel's stock may be a diamond the rough. Here's why.

Buy Google at $375 -- Because the Stock Is Headed for an Apple-Like Decline

Google investors have to ask whether the stock's recent decline is based on eroding fundamentals. Or is it just pure negative momentum?

5 Rocket Stocks Worth Buying This Week

These stocks have both short-term gain catalysts and longer-term growth prospects.

Should Amazon Buy Sears?

If Jeff Bezos thinks he needs thousands of Sears and Kmart stores, Amazon investors and even shoppers should worry.

Personal Finance

Sozzi: What We Shockingly Learned About Tech by Nike Eviscerating the Fuelband

Nike's decision to scrap its Fuelband wearable device comes as a shock to all tech enthusiasts. In case you missed it, Nike has apparently fired the majority of the team responsible for Fuelband development, a total of 70 out of the 200 that make up the larger Digital Sports division. We share three surprising things that were learned from this shocking decision.

Sozzi: The New Ford Police Interceptor Car Is an Intimidating Animal

Unlike in yesteryear when cops would approach wrongdoers with wimpy looking cars that looked like they could be outrun, many police departments are wielding a secret weapon in 2014, a true beast on four wheels: the Ford Interceptor.

10 Most Expensive Tickets In Major League Baseball in 2014

Baseball tickets are the least costly in major league sports, but aren't such a great deal in markets where success and loyal fans keep the money flowing all season long.

Foreign Real Estate In These Markets Will Diversify Your Portfolio

Looking to diversify your portfolio? Search no further than foreign real estate. Panama, Paris and Uruguay are among the top three markets overseas with prime real estate.

The Worst '90s Relic: Booing Courtney Love

Kurt Cobain wasn't on the Rock and Roll Hall of Fame stage because he took heroin for his stomach pain and killed himself. Courtney Love still has nothing to do with that.

Stock Market Today

Market Hustle: Stocks Mixed as Wall Street Awaits Big Earnings

U.S. stock indices are little changed on Monday after a three-day Easter holiday break and as investors await critical earnings reports in the week ahead.

Beyond Wall St.

Biotech Stocks

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

The Recent Performance of 'Baker Brother Biotech Stocks' is Awful

Healthcare's most closely followed hedge fund is losing money during the biotech bubble burst.

FDA Approves Novartis' ALK Inhibitor! Maybe...Really Soon?

Someone at Novartis screwed up today by sending out a mass email announcing the FDA approval of a new lung cancer drug ceritinib. Brand name: Zykadia. The only problem is FDA hasn't announced the approval of Zykadia yet.

Deal News

Newmont Mining (NEM) Stock Is Up On Merger Deal Speculation

Newmont Mining (NEM) shares are up in early market trading following reports of a revived merger deal with Barrick Gold (ABX).

Jobless Claims Drop Less Than Estimates, Google Sells Out of Glass

The Labor Department gave good news on the job front -- announcing that the number of Americans filing new claims for unemployment benefits rose less than expected this week.

Weibo IPO Is a Test for Twitter, Alibaba

Weibo, often referred to as the Chinese version of Twitter TWTR, will begin trading on the Nasdaq Global Select Market after the company priced its initial public offering at the low end of its expected range.

TheStreetTV
Spin Space

Jim Cramer

Jim Cramer: Watch Apple and Facebook Amid Growth-to-Value Transition

With earnings reports from tech companies like Netflix, Apple, Facebook and Amazon coming up, Jim Cramer says the data will be interesting to watch as growth stocks become value pl...

Herb Greenberg

Greenberg: The Most Important Earnings Lesson from Chipotle

With Chipotle's CMG same-store sales up an astonishing 13.5% during some of the worst winter months in recent or even distant memory: Think twice when you see any company from this...

James Rogers

The Hartford Dives Into IBM Cloud

The Hartford has signed a $500 million, six-year cloud deal with IBM as the tech giant doubles down its efforts to tap into enterprise cloud dollars.

Chris Ciaccia

Are Netflix Earnings a 'House of Cards'?

Netflix reports first-quarter earnings after the close of trading on Monday, and with the recent trouncing in the stock investors will be looking to see whether CEO Reed Hastings t...

Laurie Kulikowski

Why Chipotle Is Raising Menu Prices

Chipotle is finally doing what Wall Street has long expected - it's raising menu prices.

Philip van Doorn

Regional Banks Shine at End of Rough Week for Sector

Regional Banks bounced back on Friday, ending a rough week for the banking sector in the wake of the Federal Reserve's stress tests.

Dan Freed

SunTrust Earnings Up 16% On Cost Cuts

SunTrust Banks cut costs to report first quarter earnings of $393 million or $0.73 per share on Monday, up 16% versus a year ago and better than analyst estimates despite lower rev...

Adam Feuerstein

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

Biotech columnist Adam Feuerstein answers readers' questions about health care companies.

Ted Reed

GM's Mary Barra Wants to Talk Cars but Recall Questions Reign

GM would so like the New York Auto Show to be a forum for showing its cars and trucks, but it's tough to escape questions about the recall of 2.6 million cars.

Rocco Pendola

Should Amazon Buy Sears?

If Jeff Bezos thinks he needs thousands of Sears and Kmart stores, Amazon investors and even shoppers should worry.

Anton Wahlman

Nissan Turns Up the Heat in the Electric Car Race

Important updates on Nissan's electric car plans include swift battery improvements, a plug-in hybrid car and much more.

Leon Lazaroff

TV Station Owners Have Bigger Concerns Than Comcast-Time Warner Cable

Rather than appear duplicitous, companies owning television stations are conspicuously quiet on the subject of Comcast's proposed $45 billion acquisition of Time Warner Cable.

DOW 16,421.41 +12.87 0.08%
S&P 500 1,865.60 +0.75 0.04%
NASDAQ 4,093.0560 -2.46 -0.06%

Brokerage Partners

Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs